Sobi to host a Capital Markets Day on 18 February 2026
The CMD will feature presentations by
- Pre-registration for attendance: click here (note pre-registration is required for onsite attendance.)
This event provides an excellent opportunity for stakeholders gain insights into the company's strategic direction ahead.
Agenda in brief:
-
Guido Oelkers – CEO Sobi. Ambition 2030 -
Lydia Abad-Franch – CMO Sobi. Pipeline and innovation at Sobi -
Robert Keenan – CMO Arthrosi. Disease Deep Dive: The painful burden of severe gout -
Duane Barnes ,Sofiane Fahmy ,Norbert Oppitz – Roundtable with Regional Heads - Professor Klaus Parhofer – Disease Deep Dive: The silent risk of sHTG
- Professor Evangelos Giamarellos – Disease Deep dive: Precision medicine in sepsis
-
Henrik Stenqvist – CFO Sobi. Delivering Shareholder Value -
Guido Oelkers – CEO Sobi. Wrap up and Q&A
Sobi
Sobi® is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. Sobi has approximately 1,900 employees across
Contacts
For details on how to contact the Sobi Investor Relations Team, please click here. For Sobi Media contacts, click here.
Head of Investor Relations
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
|
Sobi to host a Capital Markets Day on |
View original content:https://www.prnewswire.co.uk/news-releases/sobi-to-host-a-capital-markets-day-on-18-february-2026-302685067.html